Percutaneous repair by MitraClip is a transcatheter technology based on the surgical Alfieri edge-to-edge repair, which involves suturing together the middle segments of the anterior and posterior mitral valve leaflets, thereby creating a "double orifice" mitral regurgitant area.5 The MitraClip system utilizes a cobalt chromium clip covered with a polypropylene fabric that grasps the leaflet and reduces mitral regurgitation (MR) by increasing the coaptation between the regurgitant valve leaflets.
ENPNewswire-August 19, 2019--FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery
Food and Drug Administration announced today that certain transcatheter heart valves are now approved for use in patients with severe aortic valve stenosis who have a low risk for death or major complications during open-heart surgery.
Edwards Lifesciences announced that the results of the randomized PARTNER 3 Trial demonstrated superiority for the SAPIEN 3 transcatheter aortic valve over outcomes with surgery.
Edwards has invested USD 35m in an exclusive right to acquire Corvia Medical, Inc., the developer of the world's first transcatheter device designed to treat heart failure with preserved or mid-range ejection fraction.
District Court for the District of New Jersey including certain disputed allegations relating to Neovasc's transcatheter mitral valve replacement (TMVR) technology including the Tiara device.
Global Banking News-February 20, 2019-Edwards passes the CE MARK for the PASCAL Transcatheter System to address the needs of patients with mitral regurgitation
[USPRwire, Thu Dec 27 2018] The expanding database of Market Research Reports Search Engine (MRRSE) has been recently updated by the addition of a new study which is titled as " Global Transcatheter Embolization and Occlusion Devices Market -- Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 -- 2026 ".